Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis
• Carcinoma
• Ewing Sarcoma
• Germ Cell Tumor
• Liver Cancer
• Rhabdomyosarcoma
• Soft Tissue Sarcoma
• Wilms Tumor

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Children's National Research Institute | Conditions: Solid Tumors, Soft Tissue Sarcoma | Phase 2 | Status: WITHDRAWN